Anavex Life Sciences Stock Analysis

AVXL Stock  USD 3.41  0.27  7.34%   
Anavex Life Sciences is undervalued with Real Value of 14.46 and Target Price of 47.75. The main objective of Anavex Life stock analysis is to determine its intrinsic value, which is an estimate of what Anavex Life Sciences is worth, separate from its market price. There are two main types of Anavex Life's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Anavex Life's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Anavex Life's stock to identify patterns and trends that may indicate its future price movements.
The Anavex Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Anavex Life is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Anavex Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Anavex Life's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

Anavex Stock Analysis Notes

About 32.0% of the company shares are held by institutions such as insurance companies. The book value of Anavex Life was presently reported as 1.65. The company recorded a loss per share of 0.54. Anavex Life Sciences had not issued any dividends in recent years. The entity had 1:4 split on the 7th of October 2015. Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system diseases. The company was incorporated in 2004 and is headquartered in New York, New York. Anavex Lf operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people. For more info on Anavex Life Sciences please contact Christopher Missling at 844 689 3939 or go to https://www.anavex.com.

Anavex Life Sciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Anavex Life's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Anavex Life Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Anavex Life Sciences generated a negative expected return over the last 90 days
Anavex Life Sciences has high historical volatility and very poor performance
Anavex Life Sciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (47.51 M) with profit before overhead, payroll, taxes, and interest of 0.
Anavex Life Sciences currently holds about 149.16 M in cash with (27.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91.
Anavex Life Sciences has a frail financial position based on the latest SEC disclosures
Latest headline from benzinga.com: ANAVEX LIFE SCIENCES CORPORATION DEADLINE ALERT Bernstein Liebhard LLP Reminds Anavex Life Sciences Corporation Investors of Upcoming Deadline

Anavex Life Sciences Upcoming and Recent Events

Earnings reports are used by Anavex Life to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Anavex Life previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
25th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

Anavex Largest EPS Surprises

Earnings surprises can significantly impact Anavex Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-05-10
2018-03-31-0.1-0.11-0.0110 
2023-05-09
2023-03-31-0.19-0.170.0210 
2023-02-07
2022-12-31-0.19-0.170.0210 
View All Earnings Estimates

Anavex Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Anavex Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anavex Life Sciences backward and forwards among themselves. Anavex Life's institutional investor refers to the entity that pools money to purchase Anavex Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Sg Americas Securities, Llc2023-12-31
307.6 K
Bank Of New York Mellon Corp2023-12-31
256.1 K
Nuveen Asset Management, Llc2023-12-31
240.4 K
Rafferty Asset Management, Llc2023-12-31
232 K
Barclays Plc2023-12-31
210.4 K
Ubs Group Ag2023-12-31
205.3 K
Bank Of America Corp2023-12-31
204.9 K
Swiss National Bank2023-12-31
161.5 K
State Of Wisconsin Investment Board2023-12-31
136.8 K
Blackrock Inc2023-12-31
6.7 M
Vanguard Group Inc2023-12-31
4.4 M
Note, although Anavex Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Anavex Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 302.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anavex Life's market, we take the total number of its shares issued and multiply it by Anavex Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Anavex Profitablity

Anavex Life's profitability indicators refer to fundamental financial ratios that showcase Anavex Life's ability to generate income relative to its revenue or operating costs. If, let's say, Anavex Life is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Anavex Life's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Anavex Life's profitability requires more research than a typical breakdown of Anavex Life's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.28)(0.29)
Return On Capital Employed(0.39)(0.37)
Return On Assets(0.28)(0.29)
Return On Equity(0.39)(0.40)

Management Efficiency

Anavex Life Sciences has return on total asset (ROA) of (0.207) % which means that it has lost $0.207 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3188) %, meaning that it created substantial loss on money invested by shareholders. Anavex Life's management efficiency ratios could be used to measure how well Anavex Life manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.29. Return On Capital Employed is expected to rise to -0.37 this year. At this time, Anavex Life's Total Assets are quite stable compared to the past year. Total Current Assets is expected to rise to about 186.4 M this year, although the value of Other Assets will most likely fall to about 3.7 M.
Last ReportedProjected for Next Year
Book Value Per Share 1.60  1.68 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 1.60  1.68 
Enterprise Value Over EBITDA(7.04)(7.39)
Price Book Value Ratio 3.32  3.48 
Enterprise Value Multiple(7.04)(7.39)
Price Fair Value 3.32  3.48 
Enterprise Value334.4 M351.1 M
The analysis of Anavex Life's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Anavex Life's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Anavex Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
0.567

Technical Drivers

As of the 25th of April, Anavex Life shows the risk adjusted performance of (0.09), and Mean Deviation of 3.32. Anavex Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated thirteen technical drivers for Anavex Life Sciences, which can be compared to its peers. Please confirm Anavex Life Sciences risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Anavex Life Sciences is priced correctly, providing market reflects its regular price of 3.41 per share. Given that Anavex Life has information ratio of (0.18), we suggest you to validate Anavex Life Sciences's prevailing market performance to make sure the company can sustain itself at a future point.

Anavex Life Sciences Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Anavex Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Anavex Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Anavex Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Anavex Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Anavex Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Anavex Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Anavex Life Predictive Daily Indicators

Anavex Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Anavex Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Anavex Life Corporate Filings

F4
1st of April 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
23rd of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
13th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
10Q
7th of February 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
13A
25th of January 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
22nd of January 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
12th of January 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
27th of November 2023
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify

Anavex Life Forecast Models

Anavex Life's time-series forecasting models are one of many Anavex Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Anavex Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Anavex Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Anavex Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Anavex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Anavex Life. By using and applying Anavex Stock analysis, traders can create a robust methodology for identifying Anavex entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.00  0.00 
Operating Profit Margin 0.00  0.00 
Net Profit Margin 0.00  0.00 
Gross Profit Margin 0.00  0.00 

Current Anavex Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Anavex analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Anavex analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
47.75Buy1Odds
Anavex Life Sciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Anavex analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Anavex stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Anavex Life Sciences, talking to its executives and customers, or listening to Anavex conference calls.
Anavex Analyst Advice Details

Anavex Stock Analysis Indicators

Anavex Life Sciences stock analysis indicators help investors evaluate how Anavex Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Anavex Life shares will generate the highest return on investment. By understating and applying Anavex Life stock analysis, traders can identify Anavex Life position entry and exit signals to maximize returns.
Begin Period Cash Flow149.2 M
Common Stock Shares Outstanding79.8 M
Total Stockholder Equity141.9 M
Tax Provision7000.00
Cash And Short Term Investments151 M
Cash151 M
Accounts Payable4.3 M
Net Debt-151 M
50 Day M A4.9134
Total Current Liabilities12.5 M
Other Operating Expenses55.8 M
Stock Based Compensation16.4 M
When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Anavex Stock analysis

When running Anavex Life's price analysis, check to measure Anavex Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anavex Life is operating at the current time. Most of Anavex Life's value examination focuses on studying past and present price action to predict the probability of Anavex Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anavex Life's price. Additionally, you may evaluate how the addition of Anavex Life to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is Anavex Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Return On Assets
(0.21)
Return On Equity
(0.32)
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.